Detalles de la búsqueda
1.
Baseline levels of dynamic CD4+ T cell adhesion to MAdCAM-1 correlate with clinical response to vedolizumab treatment in ulcerative colitis: a cohort study.
BMC Gastroenterol
; 20(1): 103, 2020 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32293299
2.
Similar Inhibition of Dynamic Adhesion of Lymphocytes From IBD Patients to MAdCAM-1 by Vedolizumab and Etrolizumab-s.
Inflamm Bowel Dis
; 24(6): 1237-1250, 2018 05 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-29788362
3.
Clinical Response to Vedolizumab in Ulcerative Colitis Patients Is Associated with Changes in Integrin Expression Profiles.
Front Immunol
; 8: 764, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28717358
Resultados
1 -
3
de 3
1
Próxima >
>>